TMCI
Treace Medical Concepts, Inc.$4.14+0.23 (+5.88%)Prev Close$3.91·MCap$124.4M·P/E—·Vol863.0K·Yield—
▲
Buys (12M)
5
$1.20M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$1.20M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Treace Medical Concepts, Inc. (TMCI) has been exclusively buying, with 5 insider purchases totaling $1.20M and 0 insider sales totaling $0.00. The most recent insider transaction was by Treace John T. (director, 10 percent owner, officer: Chief Executive Officer), who purchased $99.2K worth of shares on Jun 12, 2026. Treace Medical Concepts, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $124.4M.
TMCI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 24,606 | $4.03 | $99.2K | 7,348,439 |
| Jun 11, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 52,317 | $4.03 | $211.0K | 7,376,150 |
| Jun 1, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 50,000 | $3.56 | $177.9K | 7,323,833 |
| May 28, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 115,520 | $2.95 | $340.6K | 7,273,833 |
| May 14, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 153,763 | $2.44 | $375.5K | 7,158,313 |
| May 8, 2025 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Sell | 1,894 | $7.54 | $14.3K | 0 |
| Mar 17, 2025 | Scanlan Sean F. | Chief Innovation Officer | Sell | 50,000 | $7.97 | $398.5K | 0 |
| Mar 4, 2025 | Treace John T. | Chief Executive Officer | Buy | 60,000 | $8.73 | $524.1K | 0 |
| Sep 17, 2024 | Treace John T. | Chief Executive Officer | Buy | 50,000 | $5.31 | $265.6K | 6,523,095 |
| Aug 19, 2024 | TREACE JAMES T | Buy | 84,000 | $5.96 | $501.0K | 1,223,441 | |
| Aug 15, 2024 | Treace John T. | Chief Executive Officer | Buy | 85,000 | $6.00 | $510.3K | 6,473,095 |
| Jun 11, 2024 | Treace John T. | Chief Executive Officer | Buy | 45,000 | $5.88 | $264.6K | 6,388,095 |
| Jun 3, 2024 | TREACE JAMES T | Buy | 25,000 | $6.05 | $151.3K | 1,139,441 | |
| May 30, 2024 | TREACE JAMES T | Buy | 25,000 | $5.20 | $130.1K | 1,114,441 | |
| May 29, 2024 | TREACE JAMES T | Buy | 50,000 | $5.07 | $253.5K | 1,089,441 | |
| May 28, 2024 | MOTT RICHARD W | Buy | 18,000 | $5.19 | $93.5K | 1,072,944 | |
| May 23, 2024 | MOTT RICHARD W | Buy | 12,100 | $4.99 | $60.4K | 1,054,944 | |
| May 20, 2024 | Treace John T. | Chief Executive Officer | Buy | 100,000 | $5.56 | $556.2K | 6,343,095 |
| May 14, 2024 | Kiernan Jane E | Buy | 19,356 | $5.17 | $100.0K | 24,941+347% | |
| May 14, 2024 | Treace John T. | Chief Executive Officer | Buy | 150,000 | $5.12 | $767.8K | 6,243,095 |
| May 13, 2024 | BAKEWELL JOHN K | Buy | 130,000 | $4.57 | $594.6K | 135,048New Position | |
| May 13, 2024 | Jain Deepti | Buy | 25,000 | $4.50 | $112.6K | 31,235+401% | |
| May 13, 2024 | MOTT RICHARD W | Buy | 120,000 | $4.51 | $540.9K | 1,027,753 | |
| May 13, 2024 | TREACE JAMES T | Buy | 228,000 | $4.54 | $1.03M | 1,039,441+28% | |
| May 13, 2024 | Treace John T. | Chief Executive Officer | Buy | 300,000 | $4.57 | $1.37M | 6,093,095 |
| Mar 29, 2024 | TREACE JAMES T | Sell | 50,000 | $20.29 | $1.01M | 1,039,941 | |
| Jun 8, 2023 | BAYS F BARRY | Sell | 1,090,821 | $26.51 | $28.92M1.7% OS | 1,042,318-51% | |
| May 18, 2023 | Scanlan Sean F. | Chief Innovation Officer | Sell | 25,000 | $25.44 | $636.0K | 32,395-44% |
| May 2, 2023 | TREACE JAMES T | Director | Sell | 50,000 | $25.05 | $1.25M | 871,441 |
| Apr 28, 2023 | BAYS F BARRY | Director | Sell | 27,804 | $25.47 | $708.0K | 1,102,421 |
| Apr 13, 2023 | BAYS F BARRY | Director | Sell | 86,160 | $26.27 | $2.26M | 1,160,021 |
| Apr 10, 2023 | MOTT RICHARD W | Director | Sell | 4,043 | $26.00 | $105.1K | 905,000 |
| Apr 5, 2023 | MOTT RICHARD W | Director | Sell | 15,957 | $26.00 | $414.9K | 924,799 |
| Mar 31, 2023 | MOTT RICHARD W | Director | Sell | 133,498 | $25.54 | $3.41M | 1,020,000 |
| Mar 31, 2023 | TREACE JAMES T | Director | Sell | 50,000 | $25.86 | $1.29M | 911,441 |
| Mar 30, 2023 | BAYS F BARRY | Director | Sell | 58,698 | $25.16 | $1.48M | 1,237,242 |
| Mar 17, 2023 | Owens Daniel E. | Sell | 6,250 | $22.87 | $143.0K | 30,914 | |
| Mar 17, 2023 | TIMBIE THOMAS E | Director | Sell | 50,000 | $23.03 | $1.15M | 1,149,069 |
| Mar 15, 2023 | BAYS F BARRY | Director | Sell | 18,800 | $23.70 | $445.5K | 1,273,963 |
| Mar 10, 2023 | Berutti Aaron | Sr. VP, Sales | Sell | 733 | $24.41 | $17.9K | 13,042 |
| Mar 10, 2023 | Elder Scot Michael | *See "Remarks" | Sell | 177 | $24.41 | $4.3K | 22,421 |
| Mar 10, 2023 | Hair Mark | Chief Financial Officer | Sell | 1,040 | $24.41 | $25.4K | 27,110 |
| Mar 10, 2023 | MOTT RICHARD W | Director | Sell | 46,502 | $23.26 | $1.08M | 1,080,000 |
| Mar 10, 2023 | Owens Daniel E. | Sell | 411 | $24.41 | $10.0K | 10,289 | |
| Mar 10, 2023 | Scanlan Sean F. | Chief Innovation Officer | Sell | 505 | $24.41 | $12.3K | 9,470 |
| Mar 10, 2023 | Treace John T. | Chief Executive Offer | Sell | 2,075 | $24.41 | $50.7K | 5,539,380 |
| Mar 3, 2023 | MOTT RICHARD W | Director | Sell | 50,000 | $21.35 | $1.07M | 1,105,000 |
| Mar 2, 2023 | TREACE JAMES T | Director | Sell | 50,000 | $21.49 | $1.07M | 974,125 |
| Feb 23, 2023 | BAYS F BARRY | Director | Sell | 18,800 | $21.86 | $410.9K | 1,291,683 |
| Feb 17, 2023 | Scanlan Sean F. | Chief Innovation Officer | Sell | 25,000 | $21.69 | $542.2K | 9,975-71% |
Showing 1–50 of 131
1 / 3
TMCI Insider Buying Activity
The following table shows recent insider purchases of Treace Medical Concepts, Inc. (TMCI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 24,606 | $4.03 | $99.2K | 7,348,439 |
| Jun 11, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 52,317 | $4.03 | $211.0K | 7,376,150 |
| Jun 1, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 50,000 | $3.56 | $177.9K | 7,323,833 |
| May 28, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 115,520 | $2.95 | $340.6K | 7,273,833 |
| May 14, 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 153,763 | $2.44 | $375.5K | 7,158,313 |
| Mar 4, 2025 | Treace John T. | Chief Executive Officer | Buy | 60,000 | $8.73 | $524.1K | 0 |
| Sep 17, 2024 | Treace John T. | Chief Executive Officer | Buy | 50,000 | $5.31 | $265.6K | 6,523,095 |
| Aug 19, 2024 | TREACE JAMES T | Buy | 84,000 | $5.96 | $501.0K | 1,223,441 | |
| Aug 15, 2024 | Treace John T. | Chief Executive Officer | Buy | 85,000 | $6.00 | $510.3K | 6,473,095 |
| Jun 11, 2024 | Treace John T. | Chief Executive Officer | Buy | 45,000 | $5.88 | $264.6K | 6,388,095 |
| Jun 3, 2024 | TREACE JAMES T | Buy | 25,000 | $6.05 | $151.3K | 1,139,441 | |
| May 30, 2024 | TREACE JAMES T | Buy | 25,000 | $5.20 | $130.1K | 1,114,441 | |
| May 29, 2024 | TREACE JAMES T | Buy | 50,000 | $5.07 | $253.5K | 1,089,441 | |
| May 28, 2024 | MOTT RICHARD W | Buy | 18,000 | $5.19 | $93.5K | 1,072,944 | |
| May 23, 2024 | MOTT RICHARD W | Buy | 12,100 | $4.99 | $60.4K | 1,054,944 | |
| May 20, 2024 | Treace John T. | Chief Executive Officer | Buy | 100,000 | $5.56 | $556.2K | 6,343,095 |
| May 14, 2024 | Kiernan Jane E | Buy | 19,356 | $5.17 | $100.0K | 24,941+347% | |
| May 14, 2024 | Treace John T. | Chief Executive Officer | Buy | 150,000 | $5.12 | $767.8K | 6,243,095 |
| May 13, 2024 | BAKEWELL JOHN K | Buy | 130,000 | $4.57 | $594.6K | 135,048New Position | |
| May 13, 2024 | Jain Deepti | Buy | 25,000 | $4.50 | $112.6K | 31,235+401% | |
| May 13, 2024 | MOTT RICHARD W | Buy | 120,000 | $4.51 | $540.9K | 1,027,753 | |
| May 13, 2024 | TREACE JAMES T | Buy | 228,000 | $4.54 | $1.03M | 1,039,441+28% | |
| May 13, 2024 | Treace John T. | Chief Executive Officer | Buy | 300,000 | $4.57 | $1.37M | 6,093,095 |
TMCI Insider Selling Activity
The following table shows recent insider sales of Treace Medical Concepts, Inc. (TMCI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 8, 2025 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Sell | 1,894 | $7.54 | $14.3K | 0 |
| Mar 17, 2025 | Scanlan Sean F. | Chief Innovation Officer | Sell | 50,000 | $7.97 | $398.5K | 0 |
| Mar 29, 2024 | TREACE JAMES T | Sell | 50,000 | $20.29 | $1.01M | 1,039,941 | |
| Jun 8, 2023 | BAYS F BARRY | Sell | 1,090,821 | $26.51 | $28.92M1.7% OS | 1,042,318-51% | |
| May 18, 2023 | Scanlan Sean F. | Chief Innovation Officer | Sell | 25,000 | $25.44 | $636.0K | 32,395-44% |
| May 2, 2023 | TREACE JAMES T | Director | Sell | 50,000 | $25.05 | $1.25M | 871,441 |
| Apr 28, 2023 | BAYS F BARRY | Director | Sell | 27,804 | $25.47 | $708.0K | 1,102,421 |
| Apr 13, 2023 | BAYS F BARRY | Director | Sell | 86,160 | $26.27 | $2.26M | 1,160,021 |
| Apr 10, 2023 | MOTT RICHARD W | Director | Sell | 4,043 | $26.00 | $105.1K | 905,000 |
| Apr 5, 2023 | MOTT RICHARD W | Director | Sell | 15,957 | $26.00 | $414.9K | 924,799 |
| Mar 31, 2023 | MOTT RICHARD W | Director | Sell | 133,498 | $25.54 | $3.41M | 1,020,000 |
| Mar 31, 2023 | TREACE JAMES T | Director | Sell | 50,000 | $25.86 | $1.29M | 911,441 |
| Mar 30, 2023 | BAYS F BARRY | Director | Sell | 58,698 | $25.16 | $1.48M | 1,237,242 |
| Mar 17, 2023 | Owens Daniel E. | Sell | 6,250 | $22.87 | $143.0K | 30,914 | |
| Mar 17, 2023 | TIMBIE THOMAS E | Director | Sell | 50,000 | $23.03 | $1.15M | 1,149,069 |
| Mar 15, 2023 | BAYS F BARRY | Director | Sell | 18,800 | $23.70 | $445.5K | 1,273,963 |
| Mar 10, 2023 | Berutti Aaron | Sr. VP, Sales | Sell | 733 | $24.41 | $17.9K | 13,042 |
| Mar 10, 2023 | Elder Scot Michael | *See "Remarks" | Sell | 177 | $24.41 | $4.3K | 22,421 |
| Mar 10, 2023 | Hair Mark | Chief Financial Officer | Sell | 1,040 | $24.41 | $25.4K | 27,110 |
| Mar 10, 2023 | MOTT RICHARD W | Director | Sell | 46,502 | $23.26 | $1.08M | 1,080,000 |
| Mar 10, 2023 | Owens Daniel E. | Sell | 411 | $24.41 | $10.0K | 10,289 | |
| Mar 10, 2023 | Scanlan Sean F. | Chief Innovation Officer | Sell | 505 | $24.41 | $12.3K | 9,470 |
| Mar 10, 2023 | Treace John T. | Chief Executive Offer | Sell | 2,075 | $24.41 | $50.7K | 5,539,380 |
| Mar 3, 2023 | MOTT RICHARD W | Director | Sell | 50,000 | $21.35 | $1.07M | 1,105,000 |
| Mar 2, 2023 | TREACE JAMES T | Director | Sell | 50,000 | $21.49 | $1.07M | 974,125 |
| Feb 23, 2023 | BAYS F BARRY | Director | Sell | 18,800 | $21.86 | $410.9K | 1,291,683 |
| Feb 17, 2023 | Scanlan Sean F. | Chief Innovation Officer | Sell | 25,000 | $21.69 | $542.2K | 9,975-71% |
TMCI Insiders
Treace John T.
director, 10 percent owner, officer: Chief Executive Officer
Bought $7.19MSold $98.59M
24 tradesLast: Jun 12, 2026
Similar Stocks to TMCI
ISRG
Intuitive Surgical, Inc.
$410.38-0.59%
$149.48B
SYK
Stryker Corporation
$311.49+1.97%
$117.18B
BSX
Boston Scientific Corporation
$46.98-0.38%
$72.16B
EW
Edwards Lifesciences Corporation
$84.90-0.98%
$49.50B
DXCM
DexCom, Inc.
$75.26+0.07%
$29.57B
RMD
ResMed Inc.
$193.86+0.75%
$28.44B
ZBH
Zimmer Biomet Holdings, Inc.
$88.54+1.61%
$16.88B
PEN
Penumbra, Inc.
$318.44+0.04%
$12.59B